BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24558160)

  • 1. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing.
    Martino MM; Briquez PS; Güç E; Tortelli F; Kilarski WW; Metzger S; Rice JJ; Kuhn GA; Müller R; Swartz MA; Hubbell JA
    Science; 2014 Feb; 343(6173):885-8. PubMed ID: 24558160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing.
    Martino MM; Tortelli F; Mochizuki M; Traub S; Ben-David D; Kuhn GA; Müller R; Livne E; Eming SA; Hubbell JA
    Sci Transl Med; 2011 Sep; 3(100):100ra89. PubMed ID: 21918106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain.
    Martino MM; Hubbell JA
    FASEB J; 2010 Dec; 24(12):4711-21. PubMed ID: 20671107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adipogenic potential of various extracellular matrices under the influence of an angiogenic growth factor combination in a mouse tissue engineering chamber.
    Ting AC; Craft RO; Palmer JA; Gerrand YW; Penington AJ; Morrison WA; Mitchell GM
    Acta Biomater; 2014 May; 10(5):1907-18. PubMed ID: 24296126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
    Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
    Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.
    Martino MM; Briquez PS; Ranga A; Lutolf MP; Hubbell JA
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4563-8. PubMed ID: 23487783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycans restrained in a fibrin matrix improve ECM remodelling by endothelial cells grown for vascular tissue engineering.
    Divya P; Krishnan LK
    J Tissue Eng Regen Med; 2009 Jul; 3(5):377-88. PubMed ID: 19452443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing.
    Ishihara J; Ishihara A; Fukunaga K; Sasaki K; White MJV; Briquez PS; Hubbell JA
    Nat Commun; 2018 Jun; 9(1):2163. PubMed ID: 29867149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factors with enhanced syndecan binding generate tonic signalling and promote tissue healing.
    Mochizuki M; Güç E; Park AJ; Julier Z; Briquez PS; Kuhn GA; Müller R; Swartz MA; Hubbell JA; Martino MM
    Nat Biomed Eng; 2020 Apr; 4(4):463-475. PubMed ID: 31685999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promotion of angiogenesis by growth factors integrated with ECM proteins through coiled-coil structures.
    Assal Y; Mie M; Kobatake E
    Biomaterials; 2013 Apr; 34(13):3315-23. PubMed ID: 23388150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo.
    Vorotnikova E; McIntosh D; Dewilde A; Zhang J; Reing JE; Zhang L; Cordero K; Bedelbaeva K; Gourevitch D; Heber-Katz E; Badylak SF; Braunhut SJ
    Matrix Biol; 2010 Oct; 29(8):690-700. PubMed ID: 20797438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin interaction with growth factors in the context of general ways extracellular matrix molecules regulate growth factor signaling.
    Prasad A; Clark RA
    G Ital Dermatol Venereol; 2018 Jun; 153(3):361-374. PubMed ID: 29512981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic signaling from extracellular matrix-growth factor complexes.
    Clark RA
    J Invest Dermatol; 2008 Jun; 128(6):1354-5. PubMed ID: 18478010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between extracellular matrix and growth factors in wound healing.
    Schultz GS; Wysocki A
    Wound Repair Regen; 2009; 17(2):153-62. PubMed ID: 19320882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors.
    Doukas J; Chandler LA; Gonzalez AM; Gu D; Hoganson DK; Ma C; Nguyen T; Printz MA; Nesbit M; Herlyn M; Crombleholme TM; Aukerman SL; Sosnowski BA; Pierce GF
    Hum Gene Ther; 2001 May; 12(7):783-98. PubMed ID: 11339895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.
    Cianfarani F; Zambruno G; Brogelli L; Sera F; Lacal PM; Pesce M; Capogrossi MC; Failla CM; Napolitano M; Odorisio T
    Am J Pathol; 2006 Oct; 169(4):1167-82. PubMed ID: 17003476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems.
    Uebersax L; Merkle HP; Meinel L
    Tissue Eng Part B Rev; 2009 Sep; 15(3):263-89. PubMed ID: 19416020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
    Kumazaki K; Nakayama M; Suehara N; Wada Y
    Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.
    Takashima Y; Keino-Masu K; Yashiro H; Hara S; Suzuki T; van Kuppevelt TH; Masu M; Nagata M
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F395-408. PubMed ID: 26764203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.
    Kelly BD; Hackett SF; Hirota K; Oshima Y; Cai Z; Berg-Dixon S; Rowan A; Yan Z; Campochiaro PA; Semenza GL
    Circ Res; 2003 Nov; 93(11):1074-81. PubMed ID: 14576200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.